Publicaciones (20) Publicaciones en las que ha participado algún/a investigador/a

2021

  1. 3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 10, pp. 3048-3057

  2. A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment

    Clinical and Translational Oncology, Vol. 23, Núm. 3, pp. 434-449

  3. A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization

    Scientific Reports, Vol. 11, Núm. 1

  4. Cfd simulations of radioembolization: A proof-of-concept study on the impact of the hepatic artery tree truncation

    Mathematics, Vol. 9, Núm. 8

  5. Diagnostic accuracy of visual analysis versus dual time-point imaging with 18F-FDG PET/CT for the characterization of indeterminate pulmonary nodules with low uptake

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 3, pp. 155-160

  6. Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer

    Cancers, Vol. 13, Núm. 14

  7. Engineering a genome-reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo

    Molecular Systems Biology, Vol. 17, Núm. 10

  8. Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis

    Clinical Endocrinology, Vol. 94, Núm. 3, pp. 466-472

  9. Glucocerebrosidase gene therapy induces alpha-synuclein clearance and neuroprotection of midbrain dopaminergic neurons in mice and macaques

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

  10. Highlight selection of radiochemistry and radiopharmacy developments by editorial board

    EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1

  11. Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

    EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1

  12. Immunotherapy, cancer and PET

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 2, pp. 123-135

  13. In vivo SPECT-CT imaging and characterization of technetium-99m-labeled bevacizumab-loaded human serum albumin pegylated nanoparticles

    Journal of Drug Delivery Science and Technology, Vol. 64

  14. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 5, pp. 1570-1584

  15. Pulmonary Artery Sarcoma with Low 18F-FDG Uptake

    Clinical Nuclear Medicine, Vol. 46, Núm. 2, pp. e127-e128

  16. The joint use of 99mTc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning

    EJNMMI Research, Vol. 11, Núm. 1

  17. Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma

    Physica Medica, Vol. 84, pp. 1-9

  18. Variation of enterohepatic circulation through the image with 75SeHCAT in the first 3 hours. Scintigraphic patterns and análisis of its association with the diagnosis of bile acid malabsorption

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 6, pp. 351-357

  19. [18F]-FDG PET imaging in autoimmune GFAP meningoencephalomyelitis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 3, pp. 947-948

  20. mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 207-219